Squarepoint’s Genprex GNPX Stock Holding History

Squarepoint’s Portfolio GNPX Stock Details GNPX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-3	Closed	-$27.1K	–	4227
2023 Q4	$27.1K	Buy	+3	New	+$34.6K	﹤0.01%	3900
2021 Q2	–	Sell	-1	Closed	-$160K	–	3406
2021 Q1	$160K	Buy	+1	New	+$220K	﹤0.01%	2775
2020 Q4	–	Hold	0	–	-$54K	–	3037
2020 Q3	–	Hold	0	–	–	–	2363

Other funds holding GNPX

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

NRG

Nemes Rush Group Novi, Michigan $1.05B AUM 30.08% 1-Year Est. Return

Squarepoint's GNPX Position: Q1 2024 in Review

Squarepoint sold out of Genprex (GNPX) in Q1 2024, closing a stake of 3 shares — an estimated $27.1K sold.

Squarepoint first reported a position in GNPX in Q1 2021 and held it in 2 quarters. The position peaked at $160K in Q1 2021. 8 funds tracked by Wall St. Rank hold GNPX as of Q1 2024.

Squarepoint reported no remaining Genprex position as of Q1 2024 after selling out during the quarter.
Squarepoint sold 3 Genprex shares in Q1 2024, an estimated $27.1K.
Squarepoint first reported a position in Genprex in Q1 2021 and held it in 2 quarters.
Squarepoint's Genprex position peaked at $160K in Q1 2021.
8 funds tracked by Wall St. Rank held Genprex as of Q1 2024.

Based on Squarepoint's 13F filing for Q1 2024, filed 15 May 2024.